Aura Biosciences, Inc. Common Stock

AURA US05153U1079

💰
Capitalization
Small-cap

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

🔗
Website
https://www.aurabiosciences.com
Annual Performance 1
2021 2022 2023 2024 2025
15% -44% -17% -9% 2%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
33
🙍
Insiders
8
Person Price Shares Total Published Completed
Elazzouzi Amy
PR 		6.70
USD 		7,722
Sold 		51,737
USD 		18/08/2025 18/08/2025
Johnson David Michael
 4.90
USD 		20,000
Bought 		98,000
USD 		16/05/2025 16/05/2025
Gibney Anthony S
O 		5.15
USD 		1,519
Sold 		7,823
USD 		16/05/2025 16/05/2025
Johnson David Michael
 4.90
USD 		20,000
Bought 		98,000
USD 		16/05/2025 16/05/2025
Gibney Anthony S
O 		4.90
USD 		50,000
Bought 		245,000
USD 		16/05/2025 16/05/2025
Gibney Anthony S
O 		4.90
USD 		50,000
Bought 		245,000
USD 		16/05/2025 16/05/2025
Gibney Anthony S
O 		5.15
USD 		1,519
Sold 		7,823
USD 		16/05/2025 16/05/2025
Elazzouzi Amy
VP 		5.49
USD 		897
Sold 		4,925
USD 		16/04/2025 16/04/2025
Kilroy Conor
O 		5.49
USD 		7,162
Sold 		39,319
USD 		16/04/2025 16/04/2025
Plavsic Mark
CTO 		7.75
USD 		2,151
Sold 		16,670
USD 		18/02/2025 18/02/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Aura Biosciences, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-14% -8% 6% -33% 0% 0% -43%
Last 52W Low 52W High All-Time Low All-Time High β
5.76 4.90 11.74 4.90 24.89
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Johnson David Michael 8 1,630,987.30 203,873.41 07/11/2023 16/05/2025
De Los Pinos Elisabet 7 955,032.91 136,433.27 30/10/2023 18/02/2025
Gibney Anthony S 4 505,645.70 126,411.43 16/05/2025 16/05/2025
Feder Julie B 4 423,026.96 105,756.74 30/10/2023 18/10/2024
Hopkins Janet Jill 2 130,301.88 65,150.94 18/11/2024 18/02/2025
Plavsic Mark 2 89,392.80 44,696.40 16/10/2024 18/02/2025
Elazzouzi Amy 5 81,160.49 16,232.10 29/10/2024 18/08/2025
Kilroy Conor 1 39,319.38 39,319.38 16/04/2025 16/04/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.